Biome secures distribution with Fullscript Canada
Filed with ASX · · 4 pages · English
Watch Biome Australia's latest callBiome Australia (ASX:BIO) Q1 2026 Earnings Call · Replay · Oct 22, 2025Read the transcript of Biome Australia (ASX:BIO) Q1 2026 Earnings CallMicrobiome health company Biome Australia Limited (ASX: BIO) ('Biome' or 'the Company') is pleased to announce it has secured distribution for its entire Canadian range on Fullscript, North America's dominant practitioner distribution platform, and agreed on commercial terms. Strategic significance The Fullscript partnership represents a significant milestone in Biome's Canadian expansion, providi
Earlier from Biome Australia
- Quarterly Activities & Cashflow Report
- Trading Update
- Biome Launches Human Clinical Trial on BMB18
- Q1 FY26 Revenue Guidance
- Biome Secures New Zealand Pharmacy Deal
Later from Biome Australia
- Ethics Approval Granted for BMB18 Human Clinical Trial
- Appendix 4D & Half Yearly Report
- Biome First Half FY26 Results and Highlights
- Patent Application Filed for Probiotic Strain BMB18
- Probiotical Exclusive Supply Agreement Extended
Follow Biome Australia into a list and get an email when it puts out news.
Follow Biome Australia